These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 32962557
1. Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept. Postel A, Becher P. Emerg Microbes Infect; 2020 Dec; 9(1):2180-2189. PubMed ID: 32962557 [Abstract] [Full Text] [Related]
2. The double-antigen ELISA concept for early detection of Erns -specific classical swine fever virus antibodies and application as an accompanying test for differentiation of infected from marker vaccinated animals. Meyer D, Fritsche S, Luo Y, Engemann C, Blome S, Beyerbach M, Chang CY, Qiu HJ, Becher P, Postel A. Transbound Emerg Dis; 2017 Dec; 64(6):2013-2022. PubMed ID: 28158921 [Abstract] [Full Text] [Related]
3. DIVA vaccine properties of the live chimeric pestivirus strain CP7_E2gif. von Rosen T, Rangelova D, Nielsen J, Rasmussen TB, Uttenthal Å. Vet Microbiol; 2014 Jun 04; 170(3-4):224-31. PubMed ID: 24629779 [Abstract] [Full Text] [Related]
4. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies. Aebischer A, Müller M, Hofmann MA. Vet Microbiol; 2013 Jan 25; 161(3-4):274-85. PubMed ID: 22902189 [Abstract] [Full Text] [Related]
5. Construction of chimeric bovine viral diarrhea viruses containing glycoprotein E rns of heterologous pestiviruses and evaluation of the chimeras as potential marker vaccines against BVDV. Luo Y, Yuan Y, Ankenbauer RG, Nelson LD, Witte SB, Jackson JA, Welch SK. Vaccine; 2012 Jun 06; 30(26):3843-8. PubMed ID: 22521286 [Abstract] [Full Text] [Related]
6. Efficacy of chimeric Pestivirus vaccine candidates against classical swine fever: protection and DIVA characteristics. Eblé PL, Geurts Y, Quak S, Moonen-Leusen HW, Blome S, Hofmann MA, Koenen F, Beer M, Loeffen WLA. Vet Microbiol; 2013 Mar 23; 162(2-4):437-446. PubMed ID: 23238022 [Abstract] [Full Text] [Related]
7. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. van Gennip HG, van Rijn PA, Widjojoatmodjo MN, de Smit AJ, Moormann RJ. Vaccine; 2000 Oct 15; 19(4-5):447-59. PubMed ID: 11027808 [Abstract] [Full Text] [Related]
8. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Reimann I, Depner K, Trapp S, Beer M. Virology; 2004 Apr 25; 322(1):143-57. PubMed ID: 15063124 [Abstract] [Full Text] [Related]
9. Generation and Efficacy of Two Chimeric Viruses Derived from GPE- Vaccine Strain as Classical Swine Fever Vaccine Candidates. Huynh LT, Isoda N, Hew LY, Ogino S, Mimura Y, Kobayashi M, Kim T, Nishi T, Fukai K, Hiono T, Sakoda Y. Viruses; 2023 Jul 20; 15(7):. PubMed ID: 37515273 [Abstract] [Full Text] [Related]
10. Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines. Wehrle F, Renzullo S, Faust A, Beer M, Kaden V, Hofmann MA. J Gen Virol; 2007 Aug 20; 88(Pt 8):2247-2258. PubMed ID: 17622629 [Abstract] [Full Text] [Related]
11. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV). Koenig P, Lange E, Reimann I, Beer M. Vaccine; 2007 Apr 30; 25(17):3391-9. PubMed ID: 17257713 [Abstract] [Full Text] [Related]
12. Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BErns) in pregnant sows. Lim SI, Choe S, Kim KS, Jeoung HY, Cha RM, Park GS, Shin J, Park GN, Cho IS, Song JY, Hyun BH, Park BK, An DJ. Vaccine; 2019 Jun 12; 37(27):3598-3604. PubMed ID: 31151802 [Abstract] [Full Text] [Related]
13. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1. Dräger C, Schröder C, König P, Tegtmeyer B, Beer M, Blome S. Vaccine; 2016 Sep 07; 34(39):4666-4671. PubMed ID: 27523739 [Abstract] [Full Text] [Related]
14. Safety and DIVA Capability of Novel Live Attenuated Classical Swine Fever Marker Vaccine Candidates in Pregnant Sows. Tong C, Mundt A, Meindl-Boehmer A, Haist V, Gallei A, Chen N. Viruses; 2024 Jun 28; 16(7):. PubMed ID: 39066207 [Abstract] [Full Text] [Related]
15. Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus. Wei Q, Liu Y, Zhang G. Viruses; 2021 Mar 10; 13(3):. PubMed ID: 33801868 [Abstract] [Full Text] [Related]
16. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Reimann I, Depner K, Utke K, Leifer I, Lange E, Beer M. Vet Microbiol; 2010 Apr 21; 142(1-2):45-50. PubMed ID: 19892497 [Abstract] [Full Text] [Related]
17. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs. de Smit AJ, Bouma A, van Gennip HG, de Kluijver EP, Moormann RJ. Vaccine; 2001 Jan 08; 19(11-12):1467-76. PubMed ID: 11163670 [Abstract] [Full Text] [Related]
18. P108 and T109 on E2 Glycoprotein Domain I Are Critical for the Adaptation of Classical Swine Fever Virus to Rabbits but Not for Virulence in Pigs. Xie L, Han Y, Ma Y, Yuan M, Li W, Li LF, Li M, Sun Y, Luo Y, Li S, Hu S, Li Y, Qiu HJ. J Virol; 2020 Aug 17; 94(17):. PubMed ID: 32581110 [Abstract] [Full Text] [Related]
20. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)? van Rijn PA. Vet Microbiol; 2007 Nov 15; 125(1-2):150-6. PubMed ID: 17561359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]